The Effect of Turmeric on New Onset Primary Dysmenorrhea

Batman Training and Research Hospital90 enrolled

Overview

The study was planned as 150 patients. Patients who met early-onset dysmenorrhea criteria and who met the inclusion criteria; 150 patients were divided into 2 equal groups, and NSAID during the menstrual cycle, nsai + turmeric 1 gr oral powder form treatment was planned to be started in the other group. The pain frequency and severity before and after treatment were evaluated by visual analog scale and the two groups were compared.

There are scientific publications on the use of turmeric, which constitutes the hypothesis of our study, in branches such as cardiology, neurology, infertility and chest diseases due to its anti-inflammatory, anti-aging properties. The data are planned to be evaluated by the researchers using the SPSS(Statistical Package for the Social Sciences ) 17.0 program on computer. The responses of all groups to the VAS scores are planned to be entered into the system by using the SPSS program before and after treatment. statistics (number, percentage, mean, standard deviation), chi-square and logistic regression analysis are used to compare categorical variables. Chi-square test and Mann Whitney-U test are planned to be used in comparison between groups.When examining the difference between the groups, if the p value is less than 0.05, it is planned as a proof of significant difference.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Primary Dysmenorrhea

Interventions

NaproxenDRUG

use of naproxen twice a day orally in mens time

TurmericDIETARY_SUPPLEMENT

Use of turmeric orally (1 gram powder formula) in mens time

Eligibility

Sex: FEMALEMin age: 16 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Early-onset primary dysmenorrhea (Definition: Pain that begins in less than 6 months, is not accompanied by infection, begins on the first day of menstruation and ends on the last day of menstruation) 2. Non-pregnant and breastfeeding patients 3. Between 16-35 years old 4. No anatomic pathology or disease 5. Lack of active infection 6. No history of drug use 7. BMI is less than 25 8. Those who wish to participate in the study signed the consent form 9. Smoking, non-alcoholic patients 10. Patients who completed their treatment and came to the control 11. Regular menstruation Exclusion Criteria: 1. Presence of vaginal infection such as Trichomonas vaginalis and candida albicans 2. Patients who do not want to participate in the study 3. Pregnant and nursing patients 4. Be under 16 years or older than 30 years 5. Systemic disease 6. Smoking, alcohol consumption 7. BMI higher than 25 8. People with organic pelvic pathology (ovarian cyst, fibroids, polyps) 9. People with a history of drug use 10. Patients who discontinue treatment and do not come to control 11. Irregular menstruation 12. Any history of contraindication to naproxen 13. Turmeric allergy history

Locations (1)

Batman Maternity and Child's health Hospital

Batman, Turkey (Türkiye)

Outcomes

Primary Outcomes

the effect of turmeric on visual analog scala at new onset primary dysmenorrhea

To determine the effect of turmeric use on pain severity in early onset primary .The minimum pain score for dysmenorrhea is defined as 1 maximal pain score of 10 and a significant difference is planned if there is a significant difference between pretreatment scores and post-treatment scores if at least 50 percent reduction in turmeric use is achieved.It is predicted that there is no significant difference in visual analog scale scoring less than 50 percent and treatment is not effective. Before and after the treatment of turmeric effect on visual analog scores will be compared and a significant difference will be observed if at least 50 percent improvement is detected.dysmenorrhea using visual analogue scoring. The percentage of reduction in visual analog scores will be calculated in all patients using turmeric.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.